Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lynch

Showing results (681-690 of 927) with videos related to

Pageof 93
Sort By:
Health Affairs (Project Hope)|May 8, 2018
Lessons Learned From A Study Of Genomics-Based Carrier Screening For Reproductive Decision MakingBenjamin S Wilfond, Tia L Kauffman, Gail P Jarvik, et al.
Archives of General Psychiatry|March 9, 2011
Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findingsFrances L Lynch, John F Dickerson, Greg Clarke, et al.
Journal of Medicinal Chemistry|September 30, 2005
Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3Zhen Li, Weirong Chen, Jeffrey J Hale, et al.
ACS Chemical Biology|July 9, 2024
Quantitative Measurement of Rate of Targeted Protein DegradationThomas L Lynch, Violeta L Marin, Ryan A McClure, et al.
Scientific Reports|January 14, 2021
Serum carotenoids and Pediatric Metabolic Index predict insulin sensitivity in Mexican American childrenSrinivas Mummidi, Vidya S Farook, Lavanya Reddivari, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic propertiesDooseop Kim, Liping Wang, Jeffrey J Hale, et al.
ACS Infectious Diseases|May 3, 2021
Targeting <i>Mycobacterium tuberculosis</i> CoaBC through Chemical Inhibition of 4'-Phosphopantothenoyl-l-cysteine Synthetase (CoaB) ActivityJoanna C Evans, Dinakaran Murugesan, John M Post, et al.
American Journal of Medical Genetics. Part A|January 22, 2016
Patients' ratings of genetic conditions validate a taxonomy to simplify decisions about preconception carrier screening via genome sequencingMichael C Leo, Carmit McMullen, Benjamin S Wilfond, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
CCR5 antagonists: bicyclic isoxazolidines as conformationally constrained N-1-substituted pyrrolidinesChristopher L Lynch, Amy L Gentry, Jeffrey J Hale, et al.
Psychiatric Services (Washington, D.C.)|February 3, 2015
Psychiatric comorbidity and 30-day readmissions after hospitalization for heart failure, AMI, and pneumoniaBrian K Ahmedani, Leif I Solberg, Laurel A Copeland, et al.
Pageof 93

Showing results (681-690 of 927) with videos related to

Sort By:
Pageof 93
Health Affairs (Project Hope)|May 8, 2018
Lessons Learned From A Study Of Genomics-Based Carrier Screening For Reproductive Decision MakingBenjamin S Wilfond, Tia L Kauffman, Gail P Jarvik, et al.
Archives of General Psychiatry|March 9, 2011
Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findingsFrances L Lynch, John F Dickerson, Greg Clarke, et al.
Journal of Medicinal Chemistry|September 30, 2005
Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3Zhen Li, Weirong Chen, Jeffrey J Hale, et al.
ACS Chemical Biology|July 9, 2024
Quantitative Measurement of Rate of Targeted Protein DegradationThomas L Lynch, Violeta L Marin, Ryan A McClure, et al.
Scientific Reports|January 14, 2021
Serum carotenoids and Pediatric Metabolic Index predict insulin sensitivity in Mexican American childrenSrinivas Mummidi, Vidya S Farook, Lavanya Reddivari, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic propertiesDooseop Kim, Liping Wang, Jeffrey J Hale, et al.
ACS Infectious Diseases|May 3, 2021
Targeting <i>Mycobacterium tuberculosis</i> CoaBC through Chemical Inhibition of 4'-Phosphopantothenoyl-l-cysteine Synthetase (CoaB) ActivityJoanna C Evans, Dinakaran Murugesan, John M Post, et al.
American Journal of Medical Genetics. Part A|January 22, 2016
Patients' ratings of genetic conditions validate a taxonomy to simplify decisions about preconception carrier screening via genome sequencingMichael C Leo, Carmit McMullen, Benjamin S Wilfond, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
CCR5 antagonists: bicyclic isoxazolidines as conformationally constrained N-1-substituted pyrrolidinesChristopher L Lynch, Amy L Gentry, Jeffrey J Hale, et al.
Psychiatric Services (Washington, D.C.)|February 3, 2015
Psychiatric comorbidity and 30-day readmissions after hospitalization for heart failure, AMI, and pneumoniaBrian K Ahmedani, Leif I Solberg, Laurel A Copeland, et al.
Pageof 93